fig1
![The use of targeted LNP/mRNA technology to generate functional, transient CAR T cells and treat cardiac injury <i>in vivo</i>](https://image.oaes.cc/f27b3ea6-3a94-4f11-963a-2f0a93ee9db5/4757.fig.1.jpg)
Figure 1. The molecular events showing the generation of transient FAPCAR T cells using CD5-targeted LNPs. Adapted from Rurik et al.[1]. LNPs: Lipid nanoparticles.
Figure 1. The molecular events showing the generation of transient FAPCAR T cells using CD5-targeted LNPs. Adapted from Rurik et al.[1]. LNPs: Lipid nanoparticles.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/